Brad Bostic founded hc1 to improve lives with high-value care. By transforming lab data into personalized healthcare insights, he believed hc1 would empower health systems to ensure patients get the right diagnostic lab tests and the right prescriptions resulting in the best possible outcomes. That belief is now reality as more than 1,000 lab and health system locations utilize the hc1 Platform to personalize care and eliminate waste for tens of millions of patients each year. Today, hc1 has grown to become the bioinformatics leader in precision testing and prescribing with many of the world’s most progressive health systems and laboratories leveraging its solutions to deliver scalable personalized medicine. Brad has been building and leading innovative cloud technology companies for more than two decades. He is well-known as a top innovator in the healthcare technology market and was recently recognized as one of Indiana’s top leaders in the Indianapolis Business Journal’s 40-Under-40.
Labs are working around the clock to support surging COVID-19 testing demands in regional hot-spots, while public health professionals need a unified national view that spans thousands of locations and organizations. hc1’s specialized focus on lab bioinformatics puts us in a unique position to deliver up-to-date national insight into the spread of COVID-19. The hc1 Platform integrates and organizes the largest repository of live laboratory orders and results in the United States, so when the new coronavirus hit, we saw the development of this dashboard as a critical contribution we needed to make in support of public health.2 May 2021